Despite increasing inflation and manufacturing costs, the Argentinean pharmaceutical industry has managed to keep drug prices low. In order to increase affordability and maintain growth, the government decided to provide a discount of 30% across 600 various drugs.
The effort was very successful, so demand has continued to rise significantly. Generally, the Argentinean pharmaceutical market is dominated by local players that hold a 55% share (leading companies are Roemmers and Bagó). Nevertheless, the demand for innovative and niche products in Argentina creates big opportunities in this promising market.